Vernon Sondak, MD, discusses the importance of accurately distinguishing advanced cutaneous squamous cell carcinoma from basal cell carcinoma.
Vernon K. Sondak, MD
Advertisement
Articles by Vernon K. Sondak, MD
Vernon K. Sondak, MD, chair of the Department of Cutaneous Oncology at Moffitt Cancer Center, discusses the use of ipilimumab in the adjuvant setting for patients with melanoma.
Vernon K. Sondak, MD, chair of the Department of Cutaneous Oncology at Moffitt Cancer Center in Tampa, Florida, talks about personalized medicine when treating patients with melanoma.
Advertisement
Latest Updated Articles
Dr. Sondak on Personalizing the Treatment of MelanomaOctober 24th 2013
- Dr. Sondak on Ipilimumab in Melanoma
November 7th 2013
Advertisement
Advertisement
Trending on OncLive
1
Frontline Sac-TMT Plus Pembrolizumab Meets PFS End Point in PD-L1–Negative, Nonsquamous NSCLC
2
Pembrolizumab Monotherapy Improves PFS vs Chemotherapy in Frontline dMMR Endometrial Cancer
3
CAR T-Cell Engineering Produces Early Efficacy Signals in Glioblastoma
4
Copper-Induced Cell Death Activates Immune System, May Help Overcome Immunotherapy Resistance
5